Berallo, Jeaih Guadette S.

HRN: 14-72-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2023
CEFUROXIME 750MG (VIAL)
06/18/2023
06/25/2023
IVT
580mg
Q8
UTI
Waiting Final Action 
06/19/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/19/2023
06/25/2023
IVT
9mL
TID
Infectious Diarrhea
Waiting Final Action 
09/13/2023
CEFTRIAXONE 1G (VIAL)
09/13/2023
09/19/2023
IV
900mg
Q12
Pcap C, Uti
Waiting Final Action 
09/15/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
09/15/2023
09/21/2023
PO
1ml
QID
7 Days
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: